FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to pharmaceutical industry and discloses a means of treating joints diseases in the form of a lyophilizate containing glucosamine sulfate, chondroitin sulfate, trometamol, it differs in that in order to increase stability, it additionally contains sodium metabisulfite in the following ratio of components, wt. %: glucosamine sulfate 5.0–92.9; chondroitin sulfate 5.0–92.9; trometamol 0.1–2.0 and sodium metabisulfite 0.1–2.0.
EFFECT: treatment for joints diseases in the form of a lyophilizate is proposed.
1 cl, 7 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 |
|
RU2827073C1 |
| AGENT FOR TREATMENT OF JOINT DISEASES | 2005 |
|
RU2290922C1 |
| CHONDROITIN SULFATE SOLUTION FOR INTRAMUSCULAR ADMINISTRATION AND METHOD FOR ITS PREPARATION | 2015 |
|
RU2623050C2 |
| PREPARATION FOR SYMPTOMATIC TREATMENT OF LOCOMOTOR APPARATUS DISEASES AND PREPARATION METHOD THEREOF | 2016 |
|
RU2614958C1 |
| MEANS FOR TREATING PATIENTS FOR ARTICULATION DISEASES | 2005 |
|
RU2292203C1 |
| AGENT FOR TREATING DEGENERATIVE PROCESSES OF MUSCULOSKELETAL SYSTEM | 2024 |
|
RU2827071C1 |
| LYOPHILISED PHARMACEUTICAL COMPOSITION FOR PREPARING SOLUTION FOR INJECTIONS FOR TREATING DEGENERATE-DYSTROPHIC LOCOMOTOR DISEASES AND METHOD FOR PREPARING IT | 2011 |
|
RU2458693C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| METHOD FOR TREATMENT OF JOINT DISEASES | 2021 |
|
RU2777213C1 |
| SOLUTION FOR INTRAVENOUS AND INTRAMUSCULAR INTRODUCTION BASED ON ETHYL-METHYL-HYDROXYPYRIDINE SUCCINATE AND METHOD OF PRODUCTION THEREOF | 2015 |
|
RU2605825C1 |
